SpyGlass AMEA Registry
NCT02281019 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 526
Last updated 2019-07-10
Summary
The purpose of this study is to document indications for cholangioscopy and clinical utility of the SpyGlass Direct Visualization System (DVS) throughout the AMEA (Asia, Middle-East, Africa) region when used per standard of practice.
Conditions
- Biliary Stricture
- Biliary Obstruction Due to Common Bile Duct Stone
- Periampullary Tumor
- Hemobilia
Interventions
- PROCEDURE
-
ERCP (Endoscopic Retrograde Cholangiopancreatography)
ERCP procedure will be performed to visualize bile ducts.
- DEVICE
-
SpyGlass DVS and SpyGlass Digital Simple (DS)
Cholangioscopy using SpyGlass™ DVS or SpyGlass DS will be performed post ERCP for direct viewing of the bile ducts. What is seen during the procedure will determine a course of treatment. Among the options are biopsies taken, stones treated/removed, or a stent placed
Sponsors & Collaborators
-
Boston Scientific Corporation
lead INDUSTRY
Principal Investigators
-
Benedict Devereaux · Royal Brisbane and Women's Hospital
-
James Lau · Prince of Wales Hospital
-
Randhir Sud · Institute of Digestive & Hepatobiliary Sciences
-
Saad Niaz · Civil Hospital Karachi
-
Abdulrahman Aljebreen · King Khalid University Hospital
-
Ang Tiing Leong · Changi General Hospital Pte Ltd.
-
Jorg Reichenberger · Netcare Unitas Hospital
-
Jong Moon · Soon Chun Hyang University
-
Rungsun Rerknimitr · King Chulalongkorn Memorial Hospital
-
Ichiro Yasuda · Teikyo University Mizonokuchi Hospital
-
Arthur J. Kaffes · Royal Prince Alfred Hospital, Sydney, Australia
-
Nam Q. Nguyen · Royal Adelaide Hospital
-
Amit Maydeo · Baldota Institute of Digestive Sciences
-
Mohan Ramchandani · Asian Institute of Gastroenterology
-
Mahesh Goenka · Apollo Gleneagles Hospital
-
Professor R. Kochhar · Postgraduate Institute of Medical Education & Research
-
Takao Itoi · Tokyo Medical University
-
Masayuki Kitano · Kinki University School of Medicine
-
Jong K. Lee · Samsung Medical Center
-
Dongwan Seo · Asan Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-15
- Primary Completion
- 2016-09-30
- Completion
- 2016-10-18
Countries
- Australia
- Hong Kong
- India
- Japan
- Pakistan
- Saudi Arabia
- Singapore
- South Africa
- South Korea
- Thailand
Study Locations
More Related Trials
-
Spyglass DS Peroral Cholangioscope Guided LL or EHL Versus BML for Endoscopic Removal of Complicated Bile Duct Stones
NCT03244163 ·Status: RECRUITING ·Phase: NA
-
Cost-Effectiveness of Spyglass Direct Visualization System Facilitated Management for the Patients With Intrahepatic Bile Duct Stone and/or Large Extrahepatic Bile Duct Stone
NCT04743089 ·Status: UNKNOWN ·Phase: NA
-
A Multicenter Randomized Controlled Study of 3D Laparoscopy Versus Endoscopy in the Treatment of Choledocholithiasis
NCT04658212 ·Status: UNKNOWN ·Phase: NA
-
Non-Complex Biliary Stones DSC vs ERC
NCT03421340 ·Status: COMPLETED ·Phase: NA
-
Choledochoscopy Multicenter Registry
NCT02166099 ·Status: UNKNOWN
-
Endoscopic Treatment of Difficult Bile Duct Stones: Spyglass + EHL x Balloon Dilation of the Papilla
NCT02703077 ·Status: UNKNOWN ·Phase: PHASE4
-
SpyGlass in Post Liver Transplant Biliary Complications.
NCT02543151 ·Status: COMPLETED ·Phase: NA
-
Clinical Utility of the Spyglass System in Primary Sclerosing Cholangitis (PSC)
NCT01556555 ·Status: COMPLETED
-
Diagnosis and Percutaneous Treatment of Biliary Tract Diseases
NCT06816615 ·Status: RECRUITING ·Phase: NA
-
Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy
NCT02967926 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility of a Single-operator Peroral Cholangiopancreatioscopy System (SpyGlass)
NCT02776709 ·Status: WITHDRAWN
-
Cholangioscopy With Spyglass DS Using Percutaneous Transhepatic Cholangiography Access
NCT06096129 ·Status: COMPLETED
-
SpyGlass™ Discover Percutaneous
NCT04580940 ·Status: COMPLETED
-
Randomized Trial of Wire and Sphincterotome Systems for Biliary Cannulation
NCT02197338 ·Status: COMPLETED ·Phase: NA
-
Study of Abdominal Drainage in LCBDE+PC
NCT03120754 ·Status: UNKNOWN ·Phase: NA
-
ERC Via Double-Balloon-Enteroscopy in Patients With Biliodigestive Anastomosis
NCT00454129 ·Status: UNKNOWN ·Phase: NA
-
Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
NCT02543957 ·Status: WITHDRAWN
-
Biliary Drainage in Patients With Duodenal Metal Stent
NCT02376907 ·Status: UNKNOWN
-
Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope
NCT05429203 ·Status: COMPLETED ·Phase: NA
-
Cholangioscopic Classification of Bile Duct Lesions
NCT02794987 ·Status: COMPLETED
-
Cholangioscopic Assessment of Occluded Biliary Stent and Role of Biliary Radiofrequency Ablation
NCT03133026 ·Status: UNKNOWN ·Phase: NA
-
SpyGlass Versus ESWL for Large Common Bile Duct Stones
NCT05186350 ·Status: COMPLETED ·Phase: NA
-
Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma
NCT05233293 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Accuracy of ERCP-guided Versus Cholangioscopy-guided Tissue Acquisition in Patients With Indeterminate Biliary Strictures Suspected to be Intrinsic .
NCT03140007 ·Status: UNKNOWN ·Phase: NA
-
Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions
NCT05600803 ·Status: RECRUITING